Development of systematic diagnosis of Alzheimer disease and its related diseases using gene analysis, amloid imaging and spinal fluid analysis.

Development of systematic diagnosis of Alzheimer disease and its related diseases using gene analysis, amloid imaging and spinal fluid analysis. - Systematic diagnosis of Alzheimer disease with gene analysis, amloid imaging and spinal fluid analysis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012299

Enrollment

Registered

2013-11-14

Start date

2013-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with dementia and its related diseases

Interventions

injection of radioisotope

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with dementia and its related diseases

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Development of systematic diagnostic decision tree in patients with dementia and its related diseases, including gene analysis, amyloid imaging, and spinal fluid analysis.	—

Secondary

Measure	Time frame
Evaluation of prognostic usefulness of systematic diagnostic decision tree in patients with mild cognitive imapairment who developed dementia later.	—

Countries

Japan

Contacts

Public ContactShigenori Shimomura

Shiga Medical Center, Research Institute head office

kenkyu@res.med.shiga-pref.jp0775-82-6034

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026